PharmiWeb.com - Global Pharma News & Resources

Events

Featured Events

Events

28-Apr-2026 - 30-Apr-2026
Regulatory and governmental momentum is forcing change, fast: The Senate have recently cleared the FDA Modernization Act 3.0The FDA have developed a roadmap that’s abandoning animal testing for mAbsNIH have closed the door on animal-only grantsThe UK join the plan to phase out animal testing, announced by the Science Minster Lord Vallance Meanwhile, your pipelines are chasing novel targets that in vivo models can't predict. The 11th 3D Tissue Models Summit is where the industry comes to solve this. As the only industry-led forum dedicated to advancing organoids, organ-on-chip, and MPS, you'll connect with scientists from AbbVie, Novartis, Vertex, and many more who are validating these models, securing regulatory buy-in, and making them work at scale. The shift is happening, so make sure yo…
11th 3D Tissue Models Summit 2026
29-Apr-2026 - 30-Apr-2026
The Pharma Partnering Summit is an exclusive Life Sciences Industry event, with the aim to help companies expand their network and put together licensing deals, research collaborations and financing. Our platform brings together senior executives from different parts of the world specialising in Business Development & Licensing, Alliance Management, Research Collaborations, M&A and Investment. In addition to identifying products and partners as well as investors, the forum also serves to disseminate knowledge through expert speakers, for the best practices in the field of industry partnerships.  
Pharma Partnering US Summit 2026
The pharmaceutical industry is poised for a paradigm shift: moving away from animal models prior to human trials. This conference unites leaders from pharma, academia, and the exhibitor ecosystem to address the critical question: What is needed to engineer the post-animal drug discovery pipeline? Achieving this future requires fundamental changes – testing compounds earlier in more relevant cells, at significantly larger scales, to generate the comprehensive foundational data necessary to reduce animal dependency. Our 4 structured sessions will tackle the core transitions we need to make to achieve this future state. Relevant biology at scale will explore innovations in complex in vitro models and showcase where we are already having success. Redesign of assay and data pipelines will addre…
ELRIG Advances in Cell-based Screening 2026
Attend the Marcus Evans 21st Edition Project Portfolio and Resource Management Excellence for Pharma and BioTech conference taking place in New Jersey between 7-8 May and explore how leading pharma and biotech organizations are strengthening portfolio decision-making frameworks amid rising regulatory pressures, investment constraints, and scientific uncertainty. This event will examine evolving expectations around governance discipline, cross-functional alignment and evidence-based valuation, alongside how teams are embedding advanced analytics and AI to enhance forecasting, scenario modelling and risk assessment. Sessions will also address the operational realities of resource bottlenecks, shifting strategic priorities and accelerated development timelines, while senior leaders share best…
21st Edition Project Portfolio and Resource Management Excellence for Pharma and BioTech
Scientex Conferences proudly presents the 4th International Conference on Primary Care and Public Healthcare, taking place on May 07–08, 2026, at Kuala Lumpur, Malaysia, with an additional webinar option available from May 21–22, 2026, for those unable to attend in person. This global academic forum brings together leading researchers, healthcare professionals, policymakers, and educators to discuss current trends, breakthrough research, and practical innovations in primary care and public health. The purpose of this event is to foster interdisciplinary collaboration, highlight new strategies for healthcare delivery, and support the global exchange of knowledge and expertise in public health and clinical care. Attendees will benefit from a diverse scientific program featuring keynote addre…
4th International Conference on Primary Care and Public Healthcare
11-May-2026 - 13-May-2026
CPHI Middle East is a large-scale pharmaceutical event held in Riyadh, Saudi Arabia, connecting global and regional professionals in the pharmaceutical supply chain. The event brings together buyers, manufacturers, and suppliers from across the industry, from ingredients to finished products. It is a key platform for sourcing new business, gaining market insights, and fostering connections within the pharmaceutical sector in the Middle East and Africa. Time: 9:00 AM - 6:00 PM Venue Details: Riyadh Exhibition and Convention Center - Malham, Malham, Riyadh Province, 13380, Saudi Arabia
CPHI MIDDLE EAST
The 4th International Conference on ENT: Head and Neck Surgery will take place on May 11–12, 2026, in Kuala Lumpur, Malaysia. This premier global event will gather ENT specialists, otolaryngologists, surgeons, researchers, and healthcare professionals to exchange the latest innovations, research breakthroughs, and clinical practices in the field. Join us to network with industry leaders, present your work, and explore advancements in diagnosis, treatment, and surgical techniques in ENT and head and neck care. We appreciate your response and looking forward to your collaboration Regards,Luis ZaneConference ManagerLocation:1309 Coffeen Avenue, STE 1200Sheridan, Wyoming 82801, USA
18-May-2026 - 20-May-2026
The past few years for the TCR community have been dynamic. Approvals have signalled a viable path to commercialization, while a wave of company closures highlight the deep-rooted challenges in the current development processes. The message is clear: success is not guaranteed at approval. Addressing manufacturing costs, durability and long-term commercial viability is now mission critical for developers of TCR-based cell and biologic therapies. Spanning the full therapeutic landscape, including TCR-T, TCR mimetics, TCR-TCEs and TCR bispecifics, the 7th TCR-Based Therapies Summit cuts through the noise to focus exclusively on the challenges most acutely impacting the TCR field today. Connect with and hear directly from senior leaders driving progress at the forefront of the field, including…
7th TCR-Based Therapies Summit
The 4th Nasal Formulation and Delivery Summit is uniting formulation, delivery, and product development leaders from across pharma and biotech to advance the development of safe, effective, and commercially viable intranasal therapies. As intranasal delivery gains validation across systemic, CNS, and emergency-use indications, the pressure to optimize formulations, align drug–device strategies, and generate predictive preclinical and clinical data has never been greater.  In an era of accelerating approvals, expanding modalities, and heightened regulatory scrutiny, teams must move beyond proof-of-concept to ensure intranasal programs are scalable, translatable, and fit for commercialization. Success now depends on solving formulation and delivery challenges early, while designing deve…
4th Nasal Formulation and Delivery Summit
20-May-2026 - 21-May-2026
The Pharma Partnering Summit is an exclusive Life Sciences Industry event, with the aim to help companies expand their network and put together licensing deals, research collaborations and financing. Our platform brings together senior executives from different parts of the world specialising in Business Development & Licensing, Alliance Management, Research Collaborations, M&A and Investment. In addition to identifying products and partners as well as investors, the forum also serves to disseminate knowledge through expert speakers, for the best practices in the field of industry partnerships.  
Pharma Partnering EU Summit 2026
The 5th Circular and Self-Amplifying RNA Therapeutics Summit is the only industry forum dedicated exclusively to translating circRNA and saRNA into durable, IND-ready medicines. As the RNA field moves beyond linear mRNA, these next-generation modalities are emerging as the solution to short-lived expression, high dosing requirements, and limited therapeutic reach. With first-in-human trials now underway, increasing regulatory engagement, and expanding applications across oncology, autoimmune disease, and in vivo CAR-T, 2026 represents a critical inflection point. Developers must now prove not just promise, but performance, from durability and immunogenicity control to delivery, manufacturability, and IP strategy. Held in Boston from May 26–28, 2026, this summit brings together senior leade…
5th Circular and SaRNA Therapeutics Summit 2026
27-May-2026 - 28-May-2026
The UK Biotech Day is a leading event for the UK life sciences sector, bringing together executives and R&D scientists from pharma, biotech, medtech, techbio, investors, lawyers, patent attorneys, CROs, CDMOs, accountants, bankers, executive search agencies and others. Serving as a global gateway, it also connects the UK ecosystem with international partners to drive strategic collaborations through dealmaking, innovation, networking and finding new clients and partners.
UK Biotech Day
27-May-2026 - 28-May-2026
The Digi-Tech Pharma & AI 2026 Conference is a leading platform uniting pharmaceutical and technology leaders, healthcare innovators, regulatory authorities and solution providers to explore the evolving digital landscape in pharma. This conference promotes collaboration and knowledge exchange, enabling organizations to embrace innovation, streamline operations, and drive better patient outcomes.This event serves as a dynamic platform to explore the integration of science and technology within the pharmaceutical industry, with a strong emphasis on digital trends, AI and machine learning, digital health ecosystems, collaborative innovation, and patient-centric drug development. Key focus areas include digital drug discovery, clinical trials, data science, big data, informatics, real…
27-May-2026 - 28-May-2026
The Global Clinical Trials Connect Conference is a premier platform bringing together global leaders, clinical researchers, regulatory experts, and technology pioneers to discuss the latest innovations, best practices, and challenges in clinical trials. This conference fosters collaborations between industry stakeholders to enhance trial efficiency, regulatory compliance, patient safety, and technological adoption.This event unites experts across the clinical trial ecosystem to drive meaningful conversations on digital transformation, decentralized trials, regulatory pathways, patient engagement, and data-driven insights that are shaping the next era of clinical researchFrom adaptive trial designs to AI-powered analytics, this conference explores the latest trends, breakthrough technol…
The Marcus Evans 12th Edition Human Factors and User Experience for Medical Device Design conference taking place in San Diego between June 2-3, will explore risk-based usability assessments, regulatory compliance strategies, AI-driven design enhancements, and human-centered innovation to improve user experience in medical devices. Through expert-led panels, real-world case studies, and interactive workshops, industry leaders will share insights on usability testing, risk mitigation, user-centered design, and digital health integration. Our expert speakers will delve into strategies to enhance product usability, streamline regulatory approvals, or optimize user experience. This event provides the latest strategies, tools, and innovations to advance human factors and UX in medical device de…
12th Edition Human Factors and User Experience for Medical Device Design
02-Jun-2026 - 04-Jun-2026
Bolstering a Resurgence in Novel Approaches to Target Underlying Pathology, Address Disease Heterogeneity and Restore Hope in a More Transformative Wave of ALS and FTD Therapies. Uniting ALS Biotech, Pharma and Academia to Accelerate the Next Generation of ALS and FTD Therapeutics. Strategic moves across the sector-from Eli Lilly's Alchemab-backed ALS expansion to BMS and insistro's genetically driven collaboration and Clene Nanomedicine's regulatory-stage program-underscore the ALS community’s continued commitment to advancing impactful therapies, even in the face of clinical setbacks. With over 475 therapies in development, and 157 active or enrolling trials, and more than 350 companies actively working in ALS, and a global ALS market projected to grow from USD 667.3M in 2023 to USD 987.…
5th ALS Drug Development Summit 2026